Every SEC Form 3/4/5 on record for this filer (CIK 1918147) — 4 issuers, 24 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| PCRX | Pacira BioSciences, Inc. | Director | 2023-10-11 → 2026-06-12 | 5 | — |
| BCYC | BICYCLE THERAPEUTICS PLC | Chief Financial Officer | 2023-07-19 → 2026-01-06 | 8 | −$77,419 |
| PTCT | PTC THERAPEUTICS, INC. | Director | 2022-06-10 → 2026-01-06 | 7 | −$464,960 |
| GRPH | Graphite Bio, Inc. | Chief Financial Officer · lapsed | 2022-04-05 → 2023-02-23 | 3 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| BCYC | 2026-01-05 | Sell | 2,456 | $6.45 | $15,841 | 88,959 |
| BCYC | 2026-01-05 | Sell | 1,878 | $6.54 | $12,282 | 87,081 |
| BCYC | 2026-01-02 | Sell | 3,289 | $6.80 | $22,365 | 91,415 |
| BCYC | 2025-10-02 | Sell | 265 | $8.61 | $2,282 | 44,704 |
| BCYC | 2025-10-02 | Sell | 217 | $8.40 | $1,823 | 44,969 |
| BCYC | 2025-07-02 | Sell | 204 | $7.09 | $1,446 | 45,186 |
3 of 4 issuers are covered and open a security page; the rest are on file here only.